Riskpilot← Back to searchSign inGet full accessMedical Access MA AB
ABActiveOrg 5567975833Kopparbergsvägen 14Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20090 employees
Revenue 2025
SEK 350K
-26% vs 2024
EBITDA margin
114.3%
-8% vs 2024
Equity ratio
87.6%
Financial strength
Net profit 2025
SEK 881K
+156% vs 2024
| Revenue | SEK 350K | -26% |
| EBITDA | SEK 400K | -8% |
| Net profit | SEK 881K | +156% |
| Total assets | SEK 1,6M | -4% |
| Equity | SEK 1,4M | +51% |
| Employees | 0 | — |
Legal name
Medical Access MA AB
Org number
5567975833
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
17 december 2009
Share capital
SEK 200 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva marknadsföring och förmedling av hälso- och sjukvårdstjänster samt därmed förenlig verksamhet.
Address
Kopparbergsvägen 14
Email
roland@medicalaccess.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | — | 250 | 117 | 475 | 350 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 0 | 217 | 85 | 436 | 400 |
| Depreciation & amort. | — | −26 | −13 | — | −0 |
| EBIT | 0 | 191 | 72 | 436 | 400 |
| Net financials | — | −4 | −3 | −2 | 543 |
| Profit before tax | 0 | 188 | 69 | 434 | 62 |
| Tax | — | −39 | −14 | −89 | −62 |
| Net profit | — | 149 | 55 | 344 | 881 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | — | 1 803 | 1 772 | 1 707 | 1 637 |
| Equity | — | 552 | 607 | 952 | 1 434 |
| Long-term debt | — | 0 | 0 | — | 0 |
| Short-term debt | — | 1 251 | 1 165 | 756 | 203 |
| Total debt | — | 1 251 | 1 165 | 756 | 203 |
EBITDA margin
114.3%
This company
15.8%
Market median
+623% vs market
20212025
Equity ratio
87.6%
This company
38.2%
Market median
+129% vs market
20212025
Return on equity
61.4%
This company
18.4%
Market median
+234% vs market
20212025
Net profit margin
251.7%
This company
8.1%
Market median
+3007% vs market
20212025
Asset turnover
0.21×
This company
1.12×
Market median
-81% vs market
20212025
Debt / equity
0.14×
This company
0.62×
Market median
+77% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Audit | 2025 | |
RG Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 87% | 87% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Golden Spirit AB
Medical Access MA AB Board members of Medical Access MA AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johanna Britt Cecilia Mossberg | Audit | 0 companies |
| Roland Gunnar Martinsson | Chief Executive Officer | 0 companies |
| Nathalie Jacqueline Martinsson | Deputy Board Member | 0 companies |